Total Payments
$228,834
2024 Payments
$97,330
Companies
72
Transactions
1,242
Medicare Patients
7,951
Medicare Billing
$731,734
Payment Breakdown by Category
Research$169,748 (74.2%)
Food & Beverage$34,825 (15.2%)
Other$18,239 (8.0%)
Consulting$5,198 (2.3%)
Travel$695.25 (0.3%)
Education$129.36 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $169,748 | 8 | 74.2% |
| Food and Beverage | $34,825 | 1,203 | 15.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,239 | 11 | 8.0% |
| Consulting Fee | $5,198 | 3 | 2.3% |
| Travel and Lodging | $695.25 | 9 | 0.3% |
| Education | $129.36 | 8 | 0.1% |
Payments by Type
Research
$169,748
8 transactions
General
$59,086
1,234 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $153,341 | 115 | $0 (2024) |
| Novo Nordisk Inc | $29,321 | 275 | $0 (2024) |
| Novo Nordisk AS | $20,375 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $3,895 | 99 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,162 | 102 | $0 (2024) |
| Inari Medical, Inc. | $1,428 | 8 | $0 (2023) |
| Lilly USA, LLC | $1,410 | 72 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,331 | 58 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $1,106 | 57 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $993.09 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $97,330 | 84 | Amgen Inc. ($95,079) |
| 2023 | $12,424 | 141 | Amgen Inc. ($7,951) |
| 2022 | $4,008 | 152 | Novo Nordisk Inc ($708.90) |
| 2021 | $5,373 | 134 | Novo Nordisk Inc ($2,598) |
| 2020 | $56,264 | 166 | Amgen Inc. ($34,774) |
| 2019 | $8,879 | 170 | Novo Nordisk Inc ($4,986) |
| 2018 | $6,003 | 197 | Novo Nordisk Inc ($831.82) |
| 2017 | $38,553 | 198 | Novo Nordisk AS ($20,375) |
All Payment Transactions
1,242 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Endocrinology | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $99.44 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $120.87 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $83.76 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.82 | General |
| 10/23/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $85.04 | General |
| Category: Bone Health | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $85.53 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Cardio-renal | ||||||
| 10/02/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Diabetes Care | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: DIABETES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| 20170625_VESALIUS - CV | Amgen Inc. | $101,927 | 3 |
| VESALIUS - CV | Amgen Inc. | $34,537 | 1 |
| EX1250-4080 | Novo Nordisk AS | $20,375 | 1 |
| OSLER OLE | Amgen Inc. | $12,910 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,617 | 5,341 | $609,725 | $226,426 |
| 2022 | 26 | 2,118 | 5,207 | $602,648 | $217,687 |
| 2021 | 25 | 1,951 | 4,271 | $638,671 | $198,240 |
| 2020 | 17 | 1,265 | 1,692 | $332,102 | $89,381 |
Total Patients
7,951
Total Services
16,511
Medicare Billing
$731,734
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 383 | 1,042 | $275,395 | $87,353 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 301 | 301 | $80,269 | $38,197 | 47.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,380 | $64,571 | $25,299 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 265 | $49,553 | $15,733 | 31.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 39 | 39 | $22,357 | $10,389 | 46.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 55 | $20,384 | $7,501 | 36.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 65 | 65 | $9,383 | $4,604 | 49.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 247 | 247 | $9,335 | $4,416 | 47.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 207 | 472 | $8,090 | $3,931 | 48.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 24 | $10,080 | $3,560 | 35.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 21 | 21 | $7,208 | $3,476 | 48.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 149 | 221 | $5,918 | $2,873 | 48.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 169 | 272 | $5,745 | $2,795 | 48.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $4,796 | $2,313 | 48.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 86 | 86 | $4,675 | $2,175 | 46.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 69 | 69 | $4,444 | $2,087 | 47.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $9,370 | $1,687 | 18.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 86 | 138 | $2,680 | $1,304 | 48.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 42 | 42 | $2,705 | $1,210 | 44.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 112 | 151 | $2,347 | $1,142 | 48.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 37 | 54 | $1,814 | $888.84 | 49.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 37 | 37 | $1,429 | $700.04 | 49.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 13 | 13 | $1,462 | $450.06 | 30.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 38 | $1,148 | $392.02 | 34.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 22 | $728.20 | $356.84 | 49.0% |
About Dr. George Platt, M.D
Dr. George Platt, M.D is a Family Medicine healthcare provider based in Green Cove Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700881158.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Platt, M.D has received a total of $228,834 in payments from pharmaceutical and medical device companies, with $97,330 received in 2024. These payments were reported across 1,242 transactions from 72 companies. The most common payment nature is "" ($169,748).
As a Medicare-enrolled provider, Platt has provided services to 7,951 Medicare beneficiaries, totaling 16,511 services with total Medicare billing of $731,734. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Green Cove Springs, FL
- Active Since 06/14/2005
- Last Updated 12/22/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700881158
Products in Payments
- Repatha (Biological) $150,097
- Tresiba (Drug) $20,550
- RYBELSUS (Drug) $14,876
- Ozempic (Drug) $8,423
- Victoza (Drug) $4,738
- FARXIGA (Drug) $2,416
- EVENITY (Biological) $1,551
- TRELEGY ELLIPTA (Drug) $1,467
- FLOWTRIEVER CATHETER, S (Device) $1,428
- Kerendia (Drug) $804.16
- ENTRESTO (Drug) $775.23
- Prolia (Biological) $724.85
- XARELTO (Drug) $690.06
- INVOKANA (Drug) $641.26
- Vascepa (Drug) $606.16
- BREZTRI (Drug) $597.27
- Otezla (Drug) $590.87
- JARDIANCE (Drug) $587.83
- MOUNJARO (Drug) $548.35
- TRULICITY (Drug) $539.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.